VOYA Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.81M | Sell |
49,916
-13,280
| -21% | -$483K | ﹤0.01% | 1345 |
|
2025
Q1 | $2.29M | Sell |
63,196
-9,125
| -13% | -$330K | ﹤0.01% | 1248 |
|
2024
Q4 | $3.04M | Sell |
72,321
-89,772
| -55% | -$3.78M | ﹤0.01% | 1134 |
|
2024
Q3 | $9M | Buy |
162,093
+75,215
| +87% | +$4.18M | 0.01% | 811 |
|
2024
Q2 | $3.57M | Sell |
86,878
-15,588
| -15% | -$641K | ﹤0.01% | 1135 |
|
2024
Q1 | $4.78M | Sell |
102,466
-66,218
| -39% | -$3.09M | ﹤0.01% | 1027 |
|
2023
Q4 | $8.07M | Buy |
168,684
+93,286
| +124% | +$4.46M | 0.01% | 822 |
|
2023
Q3 | $2.69M | Sell |
75,398
-998
| -1% | -$35.6K | ﹤0.01% | 1223 |
|
2023
Q2 | $3.52M | Buy |
76,396
+19,219
| +34% | +$887K | ﹤0.01% | 1140 |
|
2023
Q1 | $2.29M | Sell |
57,177
-636
| -1% | -$25.5K | ﹤0.01% | 1302 |
|
2022
Q4 | $2.68M | Buy |
57,813
+6
| +0% | +$278 | ﹤0.01% | 1224 |
|
2022
Q3 | $2.39M | Buy |
57,807
+33,851
| +141% | +$1.4M | ﹤0.01% | 1247 |
|
2022
Q2 | $1.43M | Sell |
23,956
-2,019
| -8% | -$120K | ﹤0.01% | 1240 |
|
2022
Q1 | $1.89M | Sell |
25,975
-27,099
| -51% | -$1.97M | ﹤0.01% | 1140 |
|
2021
Q4 | $4.46M | Buy |
53,074
+35,305
| +199% | +$2.97M | 0.01% | 885 |
|
2021
Q3 | $1.6M | Sell |
17,769
-323
| -2% | -$29.1K | ﹤0.01% | 1290 |
|
2021
Q2 | $1.73M | Sell |
18,092
-9,772
| -35% | -$932K | ﹤0.01% | 1281 |
|
2021
Q1 | $3.17M | Buy |
27,864
+896
| +3% | +$102K | 0.01% | 993 |
|
2020
Q4 | $3.73M | Buy |
26,968
+7,283
| +37% | +$1.01M | 0.01% | 910 |
|
2020
Q3 | $1.62M | Hold |
19,685
| – | – | ﹤0.01% | 1099 |
|
2020
Q2 | $1.54M | Sell |
19,685
-7,381
| -27% | -$577K | ﹤0.01% | 1108 |
|
2020
Q1 | $1.2M | Sell |
27,066
-255,810
| -90% | -$11.4M | ﹤0.01% | 1147 |
|
2019
Q4 | $12.1M | Buy |
282,876
+15,042
| +6% | +$642K | 0.03% | 549 |
|
2019
Q3 | $11.5M | Sell |
267,834
-2,642
| -1% | -$113K | 0.03% | 563 |
|
2019
Q2 | $17.2M | Sell |
270,476
-116,837
| -30% | -$7.42M | 0.04% | 431 |
|
2019
Q1 | $26.9M | Buy |
387,313
+148,485
| +62% | +$10.3M | 0.06% | 291 |
|
2018
Q4 | $10.4M | Sell |
238,828
-112,780
| -32% | -$4.9M | 0.03% | 530 |
|
2018
Q3 | $26.8M | Sell |
351,608
-75,180
| -18% | -$5.74M | 0.06% | 348 |
|
2018
Q2 | $32.8M | Buy |
426,788
+408,403
| +2,221% | +$31.4M | 0.07% | 302 |
|
2018
Q1 | $937K | Buy |
18,385
+825
| +5% | +$42K | ﹤0.01% | 1421 |
|
2017
Q4 | $814K | Sell |
17,560
-698
| -4% | -$32.4K | ﹤0.01% | 1545 |
|
2017
Q3 | $972K | Sell |
18,258
-149,527
| -89% | -$7.96M | ﹤0.01% | 1456 |
|
2017
Q2 | $10.4M | Buy |
167,785
+6,816
| +4% | +$423K | 0.02% | 598 |
|
2017
Q1 | $10.9M | Buy |
160,969
+17,949
| +13% | +$1.22M | 0.03% | 576 |
|
2016
Q4 | $10.1M | Sell |
143,020
-47,574
| -25% | -$3.35M | 0.02% | 583 |
|
2016
Q3 | $13.5K | Buy |
190,594
+42,531
| +29% | +$3.02K | 0.03% | 474 |
|
2016
Q2 | $7.24M | Buy |
148,063
+10,269
| +7% | +$502K | 0.02% | 673 |
|
2016
Q1 | $8.72M | Sell |
137,794
-74,130
| -35% | -$4.69M | 0.02% | 582 |
|
2015
Q4 | $23.8M | Buy |
211,924
+195,410
| +1,183% | +$21.9M | 0.06% | 302 |
|
2015
Q3 | $1.59M | Sell |
16,514
-1,240
| -7% | -$119K | ﹤0.01% | 1084 |
|
2015
Q2 | $1.82M | Buy |
+17,754
| New | +$1.82M | ﹤0.01% | 1112 |
|